HIV and AIDS
HIV and AIDS
NIH Office of AIDS Research Issues RFI on FY 2019 Trans-NIH Research Plan
The National Institutes of Health (NIH) Office of AIDS Research (OAR) has issued a request for information (RFI) (NOT-OD-17-053) seeking input from the scientific community on the development of the fiscal year (FY) 2019 Trans-NIH Plan for HIV-Related Research. OAR is statutorily required to develop an annual Trans-NIH Plan that serves as the framework for its trans-NIH HIV/AIDS research budget. As previously reported, in August 2015 NIH released a Notice, NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding (NOT-OD-15-137), outlining its overarching HIV/AIDS research priorities along with the guidelines the agency will use to determine AIDS funding. High priority research…
Maureen Goodenow Appointed NIH Associate Director for AIDS Research
On May 18, National Institutes of Health (NIH) Director Francis Collins announced the selection of Maureen M. Goodenow as NIH Associate Director for AIDS Research and Director of the NIH Office of AIDS Research (OAR). Goodenow, currently at the University of Florida, Gainesville, is a professor of pathology, immunology, and laboratory medicine, and the Director of the Florida Center for AIDS Research. She is expected to join the agency in July. Back to this issue’s table of contents.
Office of AIDS Research Issues RFI on Trans-NIH Plan for HIV-Related Research
The National Institutes of Health (NIH) Office of AIDS Research (OAR) in the Division of Program Coordination, Planning and Strategic Initiatives (DPCPSI) recently issued a request-for-information (RFI) (NOT-OD-16-089) seeking input on the fiscal year (FY) 2018 Trans-NIH Plan for HIV-Related Research. The 2018 Plan is “designed to identify and articulate possible future directions to maximize benefits of investments in HIV/AIDS research.” In August 2015, NIH issued “new overarching priorities” for the next three to five years for HIV/AIDS research in a Notice, NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding (NOT-OD-15-137). The Notice also outlined guidelines the agency…
COSSA Joins the Call for OAR Working Group on HIV/Substance Use Disorders Research
COSSA joined organizations representing the “range of scientific, professional, and patient organizations committed to the elimination of substance use disorders and addiction through education, advocacy, and the promotion of broad public and private support for HIV/AIDS and substance use research agendas of the National Institutes of Health [NIH]” on a letter to Secretary Sylvia Mathews Burwell, Department of Health and Human Services (HHS), in response to the fiscal year (FY) 2016 Trans-NIH Plan for HIV-Related Research. The letter expresses concern “that the priorities overall and those specific to behavioral and social sciences, in particular, downplay the critical importance of reducing…
NIH Strategic Plan, PMI Cohort, HIV/AIDS, and Big Data Discussed at NIH Advisory Committee Meeting
The December 10-11 meeting of the National Institutes of Health (NIH) Advisory Committee to the Director (ACD) included an update on the progress of several high-profile initiatives NIH is developing, including the Congressionally-mandated NIH-Wide Strategic Plan, the President’s proposed Precision Medicine Cohort Program, assessment of the NIH HIV/AIDS Research Priorities, and the NIH Big Data to Knowledge (BD2k) program.
NIH Issues Guidelines for HIV/AIDS Research Priorities
In August, the National Institutes of Health (NIH) released a Notice, NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding (NOT-OD-15-137), outlining its overarching HIV/AIDS research priorities along with the guidelines the agency will use to determine AIDS funding for the next three to five years beginning in fiscal year (FY) 2016 (see related story). NIH’s Office of AIDS Research (OAR) is legislatively mandated to coordinate, plan, evaluate, and budget for the agency’s AIDS research program (see Update, June 16, 2014). The notice highlights NIH’s overarching HIV/AIDS research priorities: Research to reduce the incidence of HIV/AIDS, including the development…
OAR Outlines Overarching AIDS Research Priorities; Studies of Behavior and Social Conditions with Multiple Negative Outcomes Deemed Low Priority
At the September 1 meeting of the National Institutes of Health (NIH) Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI) Council of Councils, Acting Associate Director for AIDS Research and Acting Director for the Office of AIDS Research (OAR) Robert Eisinger provided the Council with an update on OAR’s activities, including the recent release of NIH’s high-priority areas of HIV/AIDS research and accompanying guidelines for determining funding for this research (see related story). Eisinger highlighted NIH director Francis Collins’ August 12 statement extolling the ”extraordinary progress that has been made in HIV/AIDS research over the past 34 years, transforming what…
NIH: AIDS Research Center/Developmental Research Centers on Mental Health and HIV/AIDS
The Division of AIDS Research (DAR) within the National Institute of Mental Health (NIMH) at the National Institutes of Health (NIH) is seeking applications for Center Core grants to support an HIV/AIDS Research Center (ARC) (PAR-15-197) and applications to support Developmental AIDS Research Centers (D-ARC) (PAR-15-196). ARC supports innovative, interdisciplinary research in the areas of basic research, neuro-AIDS, behavioral and social, integrated biobehavioral, clinical, translational, and implementation science. D-ARC provides infrastructure support that facilitates the development of high impact science in HIV/AIDS and mental health that is relevant to the NIMH mission. NIMH’s intent is to support research that addresses…
House Subcommittee Discusses CDC Budget; Director Questioned on Gun Violence, HIV/AIDS Research
The House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies met on March 25 to consider the administration’s fiscal year (FY) 2016 budget proposal for the Centers for Disease Control and Prevention (CDC). In attendance was CDC Director Thomas Frieden, accompanied by Beth Bell, Director of the CDC’s National Center for Zoonotic, Vector-Borne, and Enteric Diseases, and Anne Schuchat, Assistant Surgeon General and Director of the CDC’s National Center for Immunization and Respiratory Diseases. Subcommittee Chairman Tom Cole (R-OK) praised the CDC in his opening statement for protecting public health in the U.S. and abroad. He…